Transform your public affairs and market access strategy with an AI-native stakeholder intelligence system. We map, monitor, and analyze the entire policy and market landscape. Stop chasing information and start shaping outcomes.
In the pharmaceutical industry, the landscape of influence is complex and always changing. Your success depends on understanding the shifting positions of patient advocacy groups, medical societies, regulators, and competitors. Manually tracking these stakeholders is more than a full-time job—it's a major risk. This traditional approach is slow, consumes valuable resources, and leaves your team with dangerous blind spots.
This challenge is even greater in competitive therapeutic areas, like the evolving dialogue around GLP-1 treatment access. A small change in a patient group's message can impact market access. A new narrative from a competitor's lobbying can alter the conversation. When you rely on manual monitoring, you often find these critical signals days or weeks late. This forces your team to react when they should be leading the discussion. For a deeper dive into this complex environment, see our guide to public affairs in the EU.
The core issue is that keyword alerts and spreadsheets create noise, not intelligence. Without a structured way to connect the dots and identify emerging narratives, your public affairs teams risk being blindsided. You end up making high-stakes decisions with an incomplete and outdated picture of the external environment.
Policy-Insider.AI replaces inefficient manual work with powerful AI-native signal intelligence. We go beyond simple stakeholder monitoring to deliver a structured, analytical view of your entire external environment. Our platform turns the flood of public information into a clear, decision-ready asset for pharma teams.
Instead of just tracking mentions, our stakeholder intelligence system captures a wide range of external signals. This includes regulatory, political, media, and market developments. Our AI analyzes this raw data, structuring it into key facts, actor perspectives, and narrative patterns. This helps your team move from asking “What is happening?” to understanding “Why is it happening, and what should we do next?” It’s the difference between seeing a headline and knowing the full story behind it, enabling a truly proactive public affairs strategy.
Our platform is built to deliver tangible benefits that directly address the pain points of pharmaceutical public affairs and market access teams.
Our AI-driven mapping moves beyond your known contacts to identify all relevant actors and their perspectives. You can uncover hidden allies and anticipate opposition. This gives you a complete view of the networks shaping policy in your therapeutic areas.
Stop relying on static reports. Our system tracks the actions and positions of key stakeholders, from government bodies to advocacy groups. You can detect shifts in messaging and policy stances, which is one of the best practices for effective political monitoring. This gives you the early warning needed to adapt your strategy.
True stakeholder intelligence is more than just data. Our analysis engine identifies key facts and emerging narratives. It categorizes signals into specific risk types, such as regulatory, reputational, political, and market. This allows you to instantly grasp the implications for your business.
Get the intelligence you need, in the format you want. We deliver customized briefings, reports, and alerts directly to your inbox. You can also integrate insights into your existing workflows. With our integrations for platforms like Microsoft Teams, critical information reaches your team efficiently.
We start by defining your strategic goals. Our AI then maps the external environment, identifying the key actors, institutions, and narratives relevant to you.
The system continuously ingests and analyzes public information from a broad spectrum of sources. It filters out the noise to deliver structured intelligence on stakeholder positions and emerging risks.
Receive decision-ready intelligence through our web application or via custom briefings and alerts. Empower your team to engage proactively and shape your strategic environment with data-driven confidence.
“Policy-Insider.AI has transformed our stakeholder engagement. We now identify emerging contributions by Key Opinion leaders, patient groups, medical societies and the industry anywhere in the world immediately, giving us a crucial window to act. It significantly reduced our manual monitoring time and improved our response speed.”
— Lutz Dommel, CEO RPP Group, Brussesl
Standard tools tell you when your keywords are mentioned. Our stakeholder intelligence platform tells you why it matters. It doesn't just find keywords; it analyzes content to reveal actor perspectives, narrative patterns, and specific risks. This provides true intelligence, not just data collection.
Our system ingests data from a wide range of public sources. This captures regulatory, political, media, and market developments. We then tailor the source list to align with your specific strategic goals.
Absolutely. Intelligence is delivered through our web app, custom email briefings, or alerts on platforms like Teams and WhatsApp. We can even match your existing reporting formats for a seamless transition.
Yes. The platform is designed to be flexible. We tailor the scope of stakeholder monitoring and analysis to fit your specific strategic objectives and operational needs, ensuring the intelligence you receive is always relevant.
Stop being surprised by stakeholder shifts and regulatory changes. Start shaping the conversation with confidence. Request a personalized demo today and see how Policy-Insider.AI can provide the strategic clarity your pharmaceutical team needs to succeed.